{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:50:48Z","timestamp":1792785048704,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T00:00:00Z","timestamp":1783814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":93,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Vice-Chancellor for Research, Isfahan University of Medical Sciences, Isfahan, Iran","id":[{"id":"https:\/\/ror.org\/04waqzz56","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-59741-y","type":"journal-article","created":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T09:04:00Z","timestamp":1783847040000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Profiling fungal secondary metabolites with anti-leishmanial activity: an integrated in silico and in vitro study"],"prefix":"10.1038","volume":"16","author":[{"given":"Parastoo","family":"Hassani-Abharian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Ghanadian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshin","family":"Fassihi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zabihollah","family":"Shahmoradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Sadegh","family":"Damavandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvin","family":"Dehghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasoul","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azhar","family":"Salari-Jazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedamirmehdi","family":"Hejazi Dehaghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Hossein","family":"Hejazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,12]]},"reference":[{"key":"59741_CR1","unstructured":"WHO. Fact Sheet on Leishmaniasis 2023: World Health Organisation. [updated 12 January 2023] (2023). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/leishmaniasis"},{"key":"59741_CR2","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/978-981-99-6999-9_11","volume-title":"Challenges and Solutions Against Visceral Leishmaniasis","author":"S Shuhail","year":"2023","unstructured":"Shuhail, S. et al. Advances in Antileishmanial Chemotherapy. In: (eds Selvapandiyan, A., Singh, R., Puri, N. & Ganguly, N. K.) Challenges and Solutions Against Visceral Leishmaniasis. Singapore: Springer Nature Singapore; 245\u2013302. (2023)."},{"issue":"23","key":"59741_CR3","doi-asserted-by":"publisher","first-page":"20723","DOI":"10.1021\/acs.jmedchem.4c02736","volume":"67","author":"SB Bharate","year":"2024","unstructured":"Bharate, S. B. & Lindsley, C. W. Natural Products Driven Medicinal Chemistry. J. Med. Chem. 67(23), 20723\u201320730 (2024).","journal-title":"J. Med. Chem."},{"key":"59741_CR4","first-page":"118","volume":"11","author":"A Mbekeani","year":"2019","unstructured":"Mbekeani, A. et al. Mining for natural product antileishmanials in a fungal extract library. Int. J. Parasitology: Drugs Drug Resist. 11, 118\u2013128 (2019).","journal-title":"Int. J. Parasitology: Drugs Drug Resist."},{"key":"59741_CR5","doi-asserted-by":"crossref","unstructured":"St John-Campbell, S. & Bhalay, G. Target Engagement Assays in Early Drug Discovery. J. Med. Chem. (2025).","DOI":"10.1021\/acs.jmedchem.4c03115"},{"key":"59741_CR6","doi-asserted-by":"crossref","unstructured":"Bhunia, S. S., Saxena, M. & Saxena, A. K. Ligand-and structure-based virtual screening in drug discovery. Biophysical and computational tools in drug discovery 281\u2013339 (Springer, 2021).","DOI":"10.1007\/7355_2021_130"},{"issue":"8","key":"59741_CR7","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1080\/17460441.2025.2530589","volume":"20","author":"G Visbal","year":"2025","unstructured":"Visbal, G. & Navarro, M. Designing drugs against leishmaniasis: is targeting the sterol biosynthesis pathway the answer? Expert Opin. Drug Discov. 20(8), 1031\u20131044 (2025).","journal-title":"Expert Opin. Drug Discov."},{"issue":"14","key":"59741_CR8","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1017\/S0031182018000562","volume":"145","author":"GI Lepesheva","year":"2018","unstructured":"Lepesheva, G. I., Friggeri, L. & Waterman, M. R. CYP51 as drug targets for fungi and protozoan parasites: past, present and future. Parasitology 145(14), 1820\u20131836 (2018).","journal-title":"Parasitology"},{"issue":"10","key":"59741_CR9","doi-asserted-by":"publisher","first-page":"e1004427","DOI":"10.1371\/journal.ppat.1004427","volume":"10","author":"W Xu","year":"2014","unstructured":"Xu, W., Hsu, F. F., Baykal, E., Huang, J. & Zhang, K. Sterol biosynthesis is required for heat resistance but not extracellular survival in leishmania. PLoS Pathog. 10(10), e1004427 (2014).","journal-title":"PLoS Pathog"},{"issue":"8","key":"59741_CR10","doi-asserted-by":"publisher","first-page":"e1008810","DOI":"10.1371\/journal.ppat.1008810","volume":"16","author":"S Mukherjee","year":"2020","unstructured":"Mukherjee, S., Moitra, S., Xu, W., Hernandez, V. & Zhang, K. Sterol 14-\u03b1-demethylase is vital for mitochondrial functions and stress tolerance in Leishmania major. PLoS Pathog. 16(8), e1008810 (2020).","journal-title":"PLoS Pathog."},{"issue":"17","key":"59741_CR11","doi-asserted-by":"publisher","first-page":"8473","DOI":"10.3390\/ijms26178473","volume":"26","author":"S Moitra","year":"2025","unstructured":"Moitra, S., Mukherjee, S., Hernandez, V. L. & Zhang, K. C14DM Ablation Leads to Reduced Tolerance to Plasma Membrane Stress and Increased Drug Sensitivity in Leishmania major. Int. J. Mol. Sci. 26(17), 8473 (2025).","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"59741_CR12","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1056\/NEJMoa011882","volume":"346","author":"AA Alrajhi","year":"2002","unstructured":"Alrajhi, A. A. et al. Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major. N. Engl. J. Med. 346(12), 891\u2013895 (2002).","journal-title":"N. Engl. J. Med."},{"key":"59741_CR13","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ejmech.2017.04.044","volume":"135","author":"S Emami","year":"2017","unstructured":"Emami, S., Tavangar, P. & Keighobadi, M. An overview of azoles targeting sterol 14\u03b1-demethylase for antileishmanial therapy. Eur. J. Med. Chem. 135, 241\u2013259 (2017).","journal-title":"Eur. J. Med. Chem."},{"key":"59741_CR14","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jgar.2018.05.007","volume":"14","author":"A Shokri","year":"2018","unstructured":"Shokri, A. et al. Promising antileishmanial activity of novel imidazole antifungal drug luliconazole against Leishmania major: In vitro and in silico studies. J. Global Antimicrob. Resist. 14, 260\u2013265 (2018).","journal-title":"J. Global Antimicrob. Resist."},{"issue":"1","key":"59741_CR15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.bbagen.2015.10.015","volume":"1860","author":"X Yu","year":"2016","unstructured":"Yu, X. et al. Ligand tunnels in T. brucei and human CYP51: Insights for parasite-specific drug design. Biochim. et Biophys. Acta (BBA)-General Subj. 1860(1), 67\u201378 (2016).","journal-title":"Biochim. et Biophys. Acta (BBA)-General Subj."},{"issue":"4","key":"59741_CR16","doi-asserted-by":"publisher","first-page":"598","DOI":"10.3390\/ph18040598","volume":"18","author":"T Elsaman","year":"2025","unstructured":"Elsaman, T., Awadalla, M. K. A., Mohamed, M. S., Eltayib, E. M. & Mohamed, M. A. Identification of Microbial-Based Natural Products as Potential CYP51 Inhibitors for Eumycetoma Treatment: Insights from Molecular Docking, MM-GBSA Calculations, ADMET Analysis, and Molecular Dynamics Simulations. Pharmaceuticals 18(4), 598 (2025).","journal-title":"Pharmaceuticals"},{"key":"59741_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.9734\/BJPR\/2016\/26094","volume":"12","author":"N Fatima","year":"2016","unstructured":"Fatima, N. et al. Fungal metabolites and leishmaniasis: A review. Br. J. Pharm. Res. 12, 1\u201312 (2016).","journal-title":"Br. J. Pharm. Res."},{"issue":"1","key":"59741_CR18","doi-asserted-by":"publisher","first-page":"16130","DOI":"10.1038\/s41598-022-20278-5","volume":"12","author":"H Seyedhosseini Ghaheh","year":"2022","unstructured":"Seyedhosseini Ghaheh, H. et al. Targeting and ultrabroad insight into molecular basis of resistance-nodulation-cell division efflux pumps. Sci. Rep. 12(1), 16130 (2022).","journal-title":"Sci. Rep."},{"key":"59741_CR19","unstructured":"Inc, C. Molecular operating environment (MOE), Chemical Computing Group Inc. 1010 Sherbooke St 910 (West, 2016)."},{"issue":"1","key":"59741_CR20","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1038\/s41598-021-82009-6","volume":"11","author":"A Salari-Jazi","year":"2021","unstructured":"Salari-Jazi, A., Mahnam, K., Sadeghi, P., Damavandi, M. S. & Faghri, J. Discovery of potential inhibitors against New Delhi metallo-\u03b2-lactamase-1 from natural compounds: in silico-based methods. Sci. Rep. 11(1), 2390 (2021).","journal-title":"Sci. Rep."},{"issue":"1","key":"59741_CR21","doi-asserted-by":"publisher","first-page":"20088","DOI":"10.1038\/s41598-021-99618-w","volume":"11","author":"SN Esfahani","year":"2021","unstructured":"Esfahani, S. N. et al. Synthesis of some novel coumarin isoxazol sulfonamide hybrid compounds, 3D-QSAR studies, and antibacterial evaluation. Sci. Rep. 11(1), 20088 (2021).","journal-title":"Sci. Rep."},{"issue":"1","key":"59741_CR22","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1021\/ci049885e","volume":"45","author":"G Wolber","year":"2005","unstructured":"Wolber, G. & Langer, T. LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters. J. Chem. Inf. Model. 45(1), 160\u2013169 (2005).","journal-title":"J. Chem. Inf. Model."},{"issue":"12","key":"59741_CR23","doi-asserted-by":"publisher","first-page":"e00358","DOI":"10.1128\/aac.00358-24","volume":"68","author":"P Hassani-Abharian","year":"2024","unstructured":"Hassani-Abharian, P., Hejazi Dehaghani, S., Shahmoradi, Z. & Hejazi, S. H. Therapeutic effect of topical tamoxifen in murine cutaneous leishmaniasis caused by Leishmania major. Antimicrob. Agents Chemother. 68(12), e00358\u2013e00324 (2024).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"59741_CR24","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00436-010-2039-z","volume":"108","author":"N Duran","year":"2011","unstructured":"Duran, N., Muz, M., Culha, G., Duran, G. & Ozer, B. GC-MS analysis and antileishmanial activities of two Turkish propolis types. Parasitol. Res. 108(1), 95\u2013105 (2011).","journal-title":"Parasitol. Res."},{"key":"59741_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.heliyon.2024.e38331","volume":"10","author":"F Khamesipour","year":"2024","unstructured":"Khamesipour, F., Khamesipour, A., Hejazi, S. H. & Ghanadian, M. In vitro assessment of Dracocephalum lindbergii for growth inhibition, apoptosis induction, and cytokine modulation against Leishmania major. Heliyon 10, 19 (2024).","journal-title":"Heliyon"},{"issue":"7","key":"59741_CR26","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1080\/09546634.2019.1704214","volume":"32","author":"A Firooz","year":"2021","unstructured":"Firooz, A. et al. Old world cutaneous leishmaniasis in Iran: clinical variants and treatments. J. Dermatological Treat. 32(7), 673\u2013683 (2021).","journal-title":"J. Dermatological Treat."},{"issue":"97","key":"59741_CR27","doi-asserted-by":"publisher","first-page":"94510","DOI":"10.1039\/C6RA21898A","volume":"6","author":"K Sadorn","year":"2016","unstructured":"Sadorn, K. et al. Antimicrobial activity and cytotoxicity of polyketides isolated from the mushroom Xerula sp. BCC56836. RSC Adv. 6(97), 94510\u201394523 (2016).","journal-title":"RSC Adv."},{"issue":"2","key":"59741_CR28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/medsci10020024","volume":"10","author":"NS Carter","year":"2022","unstructured":"Carter, N. S. et al. Polyamine metabolism in leishmania parasites: A promising therapeutic target. Med. Sci. 10(2), 24 (2022).","journal-title":"Med. Sci."},{"issue":"12","key":"59741_CR29","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.3390\/molecules22122166","volume":"22","author":"FC Herrmann","year":"2017","unstructured":"Herrmann, F. C. et al. In silico identification and in vitro evaluation of natural inhibitors of Leishmania major pteridine reductase I. Molecules 22(12), 2166 (2017).","journal-title":"Molecules"},{"issue":"1","key":"59741_CR30","doi-asserted-by":"publisher","first-page":"9409","DOI":"10.1038\/s41467-024-53790-5","volume":"15","author":"Y Jin","year":"2024","unstructured":"Jin, Y. et al. CYP5122A1 encodes an essential sterol C4-methyl oxidase in Leishmania donovani and determines the antileishmanial activity of antifungal azoles. Nat. Commun. 15(1), 9409 (2024).","journal-title":"Nat. Commun."},{"key":"59741_CR31","unstructured":"Jin, Y. & Targeting CYP5122A1 and CYP51 for the Inhibition of Ergosterol Biosynthesis in Trypanosomatids (University of Kansas, 2023)."},{"issue":"9","key":"59741_CR32","doi-asserted-by":"publisher","first-page":"e25273","DOI":"10.1371\/journal.pone.0025273","volume":"6","author":"S Verma","year":"2011","unstructured":"Verma, S., Mehta, A. & Shaha, C. CYP5122A1, a novel cytochrome P450 is essential for survival of Leishmania donovani. PloS one. 6(9), e25273 (2011).","journal-title":"PloS one"},{"key":"59741_CR33","doi-asserted-by":"crossref","unstructured":"Grover, A., Katiyar, S. P., Singh, S. K., Dubey, V. K. & Sundar, D. A leishmaniasis study: Structure-based screening and molecular dynamics mechanistic analysis for discovering potent inhibitors of spermidine synthase. Biochim. Biophys. Acta 1824(12), 1476\u20131483. (2012).","DOI":"10.1016\/j.bbapap.2012.05.016"},{"key":"59741_CR34","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3389\/fcell.2020.00396","volume":"8","author":"MF Batista","year":"2020","unstructured":"Batista, M. F., N\u00e1jera, C. A., Meneghelli, I. & Bahia, D. The parasitic intracellular lifestyle of trypanosomatids: parasitophorous vacuole development and survival. Front. Cell. Dev. Biology. 8, 396 (2020).","journal-title":"Front. Cell. Dev. Biology"},{"issue":"9","key":"59741_CR35","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s00210-017-1387-y","volume":"390","author":"MMM Alves","year":"2017","unstructured":"Alves, M. M. M. et al. Gallic and ellagic acids: two natural immunomodulator compounds solve infection of macrophages by Leishmania major. Naunyn. Schmiedebergs Arch. Pharmacol. 390(9), 893\u2013903 (2017).","journal-title":"Naunyn. Schmiedebergs Arch. Pharmacol."},{"key":"59741_CR36","doi-asserted-by":"publisher","first-page":"1599766","DOI":"10.3389\/fcimb.2025.1599766","volume":"15","author":"L Al Samra","year":"2025","unstructured":"Al Samra, L. et al. Evaluation of Beauvericin\u2019s activity and mode of action against all life stages of L. tropica for cutaneous Leishmaniasis therapy. Front. Cell. Infect. Microbiol. 15, 1599766 (2025).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"59741_CR37","doi-asserted-by":"publisher","first-page":"1241044","DOI":"10.3389\/fitd.2023.1241044","volume":"4","author":"A Mendoza-Le\u00f3n","year":"2023","unstructured":"Mendoza-Le\u00f3n, A., Serrano, G. M. L. & Ponte-Sucre, A. Challenges in drug discovery and description targeting Leishmania spp.: enzymes, structural proteins, and transporters. Front. Trop. Dis. 4, 1241044 (2023).","journal-title":"Front. Trop. Dis."},{"issue":"1","key":"59741_CR38","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nrmicro2929","volume":"11","author":"WR Proto","year":"2013","unstructured":"Proto, W. R., Coombs, G. H. & Mottram, J. C. Cell death in parasitic protozoa: regulated or incidental? Nat. Rev. Microbiol. 11(1), 58\u201366 (2013).","journal-title":"Nat. Rev. Microbiol."},{"key":"59741_CR39","doi-asserted-by":"crossref","unstructured":"Neri, F. S. M. et al. do Antileishmanial activity evaluation of thiazolidine-2, 4-dione against Leishmania infantum and Leishmania braziliensis. Parasitol. Res. 119(7), 2263\u20132274 (2020).","DOI":"10.1007\/s00436-020-06706-3"},{"issue":"46","key":"59741_CR40","doi-asserted-by":"publisher","first-page":"31357","DOI":"10.1021\/jacs.4c11686","volume":"146","author":"O Zhang","year":"2024","unstructured":"Zhang, O. et al. Deep lead optimization: leveraging generative AI for structural modification. J. Am. Chem. Soc. 146(46), 31357\u201331370 (2024).","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"59741_CR41","doi-asserted-by":"publisher","first-page":"e0012735","DOI":"10.1371\/journal.pntd.0012735","volume":"19","author":"H Zhang","year":"2025","unstructured":"Zhang, H. et al. Progress in antileishmanial drugs: Mechanisms, challenges, and prospects. PLoS Negl. Trop. Dis. 19(1), e0012735 (2025).","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"3","key":"59741_CR42","first-page":"659","volume":"76","author":"M Radha Abbas Hasoon","year":"2021","unstructured":"Radha Abbas Hasoon, M. & Jawad Kadhim, N. Improvement of the selectivity index (SI) and cytotoxicity activity of doxorubicin drug by panax ginseng plant extract. Arch. Razi Inst. 76(3), 659\u2013666 (2021).","journal-title":"Arch. Razi Inst."},{"issue":"5","key":"59741_CR43","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1023\/A:1015810312465","volume":"9","author":"RO Potts","year":"1992","unstructured":"Potts, R. O. & Guy, R. H. Predicting skin permeability. Pharm. Res. 9(5), 663\u2013669 (1992).","journal-title":"Pharm. Res."},{"issue":"1","key":"59741_CR44","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7(1), 42717 (2017).","journal-title":"Sci. Rep."},{"key":"59741_CR45","unstructured":"PubChem, C. Summary for CID 163095, Dihydrocitrinone. [Internet]. (2025). https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Dihydrocitrinone"},{"key":"59741_CR46","doi-asserted-by":"crossref","unstructured":"Van Bocxlaer, K. et al. Topical treatment for cutaneous leishmaniasis: Dermato-pharmacokinetic lead optimization of benzoxaboroles. Antimicrob. Agents Chemother. 62(5) (2018).","DOI":"10.1128\/AAC.02419-17"},{"key":"59741_CR47","doi-asserted-by":"crossref","unstructured":"Ning, Y. et al. Molecular characterization of sterol C4-methyl oxidase in Leishmania major. Int. J. Mol. Sci. 25(20) (2024).","DOI":"10.3390\/ijms252010908"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59741-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59741-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59741-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:04:20Z","timestamp":1791907460000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59741-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,12]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["59741"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-59741-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,12]]},"assertion":[{"value":"18 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the Ethics Committee of Isfahan University of Medical Sciences, Isfahan, Iran (IR.MUI.MED.REC.1401.432).","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"31968"}}